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Introduction 
Major abdominal surgery is associated with significant risk of morbidity and mortality in 
the perioperative period, especially in the elderly or patients with significant co morbidities. 
Following the implementation of safety standards and due to better risk evaluation and 
management outcomes after anaesthesia have improved over the last decades. Although 
estimations of the perioperative complications and postoperative morbidity are difficult, it 
has been suggested that this may be between 3 and 17% of cases. It is well known, that 
using heart rate (HR), mean arterial pressure (MAP) and central venous pressure (CVP) to 
assess and guide hemodynamic support may be misleading and that they are inadequate in 
assessing perfusion or DO2. There is mounting evidence that the role of CVP to evaluate 
preload and fluid load is limited. Several studies reveal the role of intraoperative 
hemodynamic monitoring and goal-directed management in the improving outcome 
following major surgery. In this case, cardiac output (CO), oxygen delivery (DO2) or the 
mixed/central venous oxygen saturation (SvO2/ScvO2) are the end-point parameters of fluid 
resuscitation, vasoactive therapy and transfusion. Goal-directed intraoperative 
hemodynamic management results in reduced postoperative mortality and morbidity. 
Despite the increasing evidence, advanced hemodynamic monitoring has not become 
routine practice.  
For a long time the pulmonary artery catheter was the gold standard for measuring CO. To 
measure CO the use of intermittent thermodilution by the pulmonary artery catheter (PAC) 
has been decreased in surgical patients over the past decades. Evaluation of CO was 
simplified by transpulmonary indicator dilution method. The two most widely used 
techniques are the lithium dilution and thermodilution. At the time we were conducting one 
of our studies making the ground of this thesis, the optimal assessment of the preload was 
debated, although intrathoracic blood volume index (ITBVI) measured by thermodilution 
was found to be probably the most accurate method for indicating preload status of the 
critical ill patient. ITBVI was found to be superior to pulmonary artery occlusion pressure 
for indicating preload status during liver and lung transplantation. No clinical trial had 
investigated the effects of single transpulmonary thermodilution measurement guided fluid 
therapy on the intra- and postoperative inflammatory response and organ dysfunction. 
Using the methods mentioned above, knowing the oxygen content of arterial blood and 
measuring the cardiac output we can calculate the DO2 and have a sight on the imbalance 
between oxygen supply and demand. Another approach is measuring the oxygen content of 
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the returning venous blood. Assuming normal arterial oxygen content and demand we can 
estimate the DO2. Although SvO2 measured by using pulmonary artery catheter is regarded 
as the most accurate indicator of the balance between global oxygen delivery and 
consumption, there is a good evidence that ScvO2 may serve as an easily obtainable and 
reliable alternative to manage therapy in critical ill patients. 
In our clinical trials we compared the traditional, CVP guided intraoperative fluid 
management to ITBVI or ScvO2 guided hemodynamic management. In the first study our 
goal was to analyze the differences regarding the inflammatory response, in the second 
study postoperative complications were the end-point. 
 
Volumetric and pressure guided intraoperative fluid management 
Patients underwent major abdominal surgery were included and randomized into CVP or 
ITBV group. Data of 20 patients were analyzed in each group. We did not find any 
significant differences regarding the demographics and clinical parameters of the patients or 
the surgical intervention as shown in this table:  
 
 CVP (n=20) ITBV (n=20) 
Age (year) 59±9 61±11 
Sex (M/F) 10/10 8/12 
Length of operation (minutes) 220±89 230±94 
SAPS II score 16±5 14±5 
Type of operation:   
Oesophagectomy 10 9 
Total gastrectomy 5 8 
Pancreas resection 5 3 
Table 1.: Demographics; SAPS: simplified acute physiology score 
 
In the CVP group the target CVP pressure was 8–12 mmHg during surgery, as a widely 
used target. In the ITBV group the desired end-point was to keep the ITBVI between 850 
and 950 ml/m2 during the operation. The hemodynamic parameters were determined by 
single arterial thermodilution, using the PiCCO machine every 30 minutes during the 
surgery. Along with these measurements arterial blood gas analysis was performed as well. 
Blood samples were taken into serum separator tubes before anaesthesia was commenced 
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(t0), hourly during surgery then on admission to ICU (tICU), and subsequently 24, 48, and 
72h after admission (t24, t48, t72). Serum C-reactive protein (CRP), procalcitonin (PCT) 
levels were measured, than the serum was stored at -70 C degree, and tumour necrosis 
factor-α (TNF-α) levels were determined later.   
Results 
The desired hemodynamic goals were reached in both groups. There was no significant 
difference between the CVP and ITBV groups regarding CVP, ITBVI, cardiac index, stroke 
volume index (SVI), contractility, heart rate, or mean arterial pressure at any measurement 
point. There was no clinical evidence of fluid overload. Extravascular lung water (EVLW) 
was normal, and urine output was similar during the study period in both groups as shown 
in the table below: 
 
 
 
 
 CVP (n=20) ITBV (n=20) 
CVP (mmHg)   
t0 10±4 12±4 
t30 13±4 15±4 
t60 12±3 14±4 
t120 11±3 14±5 
t240 12±4 16±6 
ITBVI (ml/m
2
)   
t0 875±204 969±308 
t30 942±210 997±210 
t60 912±136 1009±289 
t120 921±136 1038±346 
t240 997±270 919±193 
CI (l/m/m
2
)   
t0 2.57±0.60 2.96±0.64 
t30 3.64±0.87 3.67±0.93 
t60 3.39±0.58 3.51±0.91 
t120 3.50±0.65 3.43±0.84 
t240 3.78±1.13 4.01±0.99 
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SVI (ml/m
2
)   
t0 36±11 44±12 
t30 45±10 49±12 
t60 42±9 49±12 
t120 47±14 50±13 
t240 49±9 42±8 
dP/dtmax (mmHg/s)   
t0 688±227 769±261 
t30 788±294 793±362 
t60 739±176 852±413 
t120 775±223 887±258 
t240 772±336 747±243 
EWLVI (ml/kg)   
t0 8±3 9±4 
t30 8±3 9±3 
t60 8±3 9±4 
t120 8±3 9±4 
t240 10±4 9±4 
Heart rate (/min)   
t0 73±17 70±15 
t30 80±11 71±15 
t60 81±14 75±16 
t120 76±13 73±16 
t240 76±14 90±25 
MAP (mmHg)   
t0 87±26 87±21 
t30 86±16 83±20 
t60 87±12 83±15 
t120 78±13 76±13 
t240 71±8 74±12 
 
Table 2.: intraoperative hemodynamic parameters 
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In the overall study population changes in the SVI showed a significant correlation with 
changes in CVP and ITBVI (r=0.288 p<0.001 and r=0.508 p<0.001, respectively, although 
the correlation was weak, especially in the CVP group. 
 
Figure 1.: correlation between the changes of SVI and CVP 
 
Figure 2.: correlation between the changes of SVI and ITBVI 
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Patients in the two groups received the same amount of crystalloid, colloid, and packed red 
blood. Hemoglobin levels in neither group changed significantly during the study. 
 
 CVP (n=20) ITBV (n=20) 
Fluid management   
crystalloid (ml) 4043±1191 4047±1841 
colloid (ml) 1255±971 1411±1040 
Packed red blood cell (U) 2±1.5 2.5±1.0 
Fresh frozen plasma (U) 2.5±1.0 2.8±1.5 
Intraoperative urine output (ml) 755±528 757±533 
Hemoglobin (g/l)   
t0 108±13 107±13 
t30 102±11 106±15 
t60 103±16 100±22 
t120 99±17 93±14 
t240 105±9 103±12 
MODS    
tICU 2±1 2±2 
t24 2±2 2±1 
t48 2±2 2±2 
t72 2±1 2±2 
ICU days 7±5 7±5 
Length of ventilation (days) 3±1 3±1 
Survival/non survival 19/1 18/2 
Table 3.: intraoperative fluid balance, postoperative outcome; MODS: multiple organ 
dysfunction score, ICU: intensive care unit 
 
TNF-α levels remained in the normal range intraoperatively and increased slightly but not 
significantly during the three postoperative days in both groups. 
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Figure 3.: changes of TNF-α during the operation and on the first three postoperative days 
 
Serum PCT levels were normal in both groups preoperatively and on arrival in the ICU, but 
within 24 h levels increased significantly. Levels remained in the pathological range for the 
rest of the study with the maximum response observed 24 hours following the surgery. 
There was no significant difference between the two groups. 
 
 
Figure 4.: changes of PCT during the operation and on the first three postoperative days 
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Serum CRP levels followed similar kinetics: they were within the normal range 
preoperatively and on arrival on ICU in both groups but increased significantly in 24 h and 
remained significantly elevated during the study period. In contrast with PCT the maximum 
response was observed 48 hours after the operation, without significant intergroup 
difference. 
 
 
Figure 5.: changes of CRP during the operation and on the first three postoperative days 
 
Regarding organ dysfunction the daily multiple organ dysfunction score (MODS) 
indicating any organ dysfunction did not differ significantly between the two groups 
throughout the study. Median length of ICU stay, length of mechanical ventilation during 
the overall ICU stay, and survival were nearly identical in the two groups (Table 3.). 
Discussion 
In our prospective randomized clinical trial we found no significant difference between the 
two groups regarding intra- or early postoperative inflammatory response and organ 
dysfunction. Interestingly, in contrast to data finding volumetric parameters better indicator 
of preload as compared to filling pressures, we found weak, but significant correlation 
between the changes of SVI and the changes of both CVP and ITBVI. Despite these 
differences between the current and previous investigations no firm conclusion can be made 
as this study was neither aimed nor designed and powered to answer the question whether 
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ITBV or CVP is the better monitoring tool of cardiac filling during major abdominal 
surgery. Our results cannot be interpreted as CVP or ITBVI were equal regarding the 
assessment of preload during major abdominal surgery.  
Previous investigations, including one conducted by our own workgroup, have shown that 
major abdominal surgery initiates an inflammatory response. In this study we examined 
three markers used for identification of inflammatory response. We could not find any 
significant differences in the postoperative kinetics of PCT, TNF-α or CRP, the levels were 
lower compared to our previous results or the pre-existing reference values. One of the 
possible explanations is that patients in the current study were successfully volume 
resuscitated by target values, reducing the risk of hypoxic tissue damage caused by 
hypovolemia, and this itself attenuated the inflammatory response. This is in accordance 
with previous findings that intraoperative hemodynamic monitoring and goal-directed 
management improves outcome following major surgery, as mentioned in the introduction. 
 
Continuous central venous oxygen saturation assisted hemodynamic therapy during 
major abdominal surgery 
Patients undergoing elective major abdominal surgeries were enrolled into our prospective 
study. Patients were randomly allocated by envelope randomisation in a block-of-ten 
fashion into control, or ScvO2 groups. Data of 41 patients in the control and 38 patients in 
the ScvO2 group were analyzed. Distribution of the types of surgical interventions is shown 
in Table 4. Two patients of the control group died on the intensive care unit during the 
postoperative period, 28 days mortality was also significantly higher in this group (1 vs. 8, 
p=0.018).  
 
 
 
 
 ScvO2 (n=38) control (n=41) p 
Age (years) 62 ± 8 62 ± 8 0.95 
Gender (M/F) 28/10 29/12 0.77 
APACHE II score 12 ± 4 11 ± 5 0.37 
ICU length of stay (days) 3 (2) 3 (2) 0.663 
Length of surgery (minutes) 247 ± 82 254 ± 45 0.76 
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Type of surgery (number of patients)    
Oesophagectomy 4 2  
Total gastrectomy 3 0  
Radical cystectomy 22 29  
Aortobifemoral bypass 5 7  
Abdominal aortic aneurysm 4 3  
ICU survival (S/NS) 38/0 39/2 0.17 
28 days survival (S/NS) 37/1 33/8 0.018* 
Table 4.: demographics 
 
Central venous saturation was continuously monitored in the ScvO2 group by using a 
fiberoptic catheter of the CeVOX monitor. In the control group cases of hypotension (as 
defined by MAP<60 mmHg) were treated with a fluid bolus if the CVP<8 mmHg, and 
norepinephrine if the CVP≥8 mmHg. In the ScvO2 group, hypotension (MAP<60 mmHg) 
was considered primarily due to hypovolemia if the ScvO2<75%, and patients received a 
fluid bolus. If the ScvO2≥75%, it was assumed that hypotension was primarily due to 
vasodilatation caused by general anaesthesia, and norepinephrine was administrated. In 
addition to low MAP there was also another trigger for intervention in this group: if ScvO2 
dropped below 75% or there was a sudden decrease by more than >3%, patients received a 
fluid bolus regardless of the MAP. During the operation arterial and central venous blood 
gas analysis were done hourly. Blood samples for laboratory assessments such as kidney 
function, liver function, blood count and inflammatory parameters such as procalcitonin 
(PCT) and C-reactive protein (CRP) were taken before the operation, on arrival to the ICU 
and 24, 48 hours later. Arterial and central venous blood gas analyses were also performed 
at these time points. 
Results 
There was no significant difference in ScvO2 between the two groups at baseline. During 
the operation there was a decrease in ScvO2 in the ScvO2 group while it remained almost 
unchanged in the control group, reaching a significant difference between the two groups 
four hours after the start of the operation. 
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Figure 6.: changes of ScvO2 during the operation 
 
The target MAP was achieved in most cases with no difference between the groups. 
Regarding the CVP there was no significant difference between the two groups throughout 
the operation. 
 
Figure 7.: changes of mean arterial pressure during the operation 
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Figure 8.: changes of central venous pressure during the operation 
 
Measurement of the urine output during the operation was complicated in 33 patients who 
underwent radical cystectomy. In their case we were unable to estimate the amount of 
urinary output. In cases where exact measurement was possible, hourly urine output 
showed a significant difference between the two groups: ScvO2 group (n=23): 165 ± 98 
ml/h vs. controls (n=23): 109 ± 92 ml/h, p=0.023. Intraoperative interventions are shown in 
Table 5. 
 
 ScvO2 (n=38) control (n=41) p 
Crystalloid infusion (ml/h) 1126 ± 471 1049 ± 431 0.46 
Colloid infusion (ml/h) 279 (161) 107 (250) <0.001* 
Vasopressor need (nr of patients) 11 15 0.47 
Dose of vasopressor (mcg/h) 37 (107) 18 (73) 0.84 
RBC transfusion (nr of patients) 24 15 0.02* 
Intraoperative blood loss (ml) 973 ± 473 983 ± 574 0.99 
Table 5.: intraoperative interventions 
 
The lactate levels were normal in both groups during the whole operation without any 
significant difference or change: 
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Figure 9.:changes of the level of lactate during the operation. 
 
Regarding postoperative complications, there were more patients with complications in the 
control group but it did not reach statistical significance. However, pulmonary 
complications as determined by the PaO2/FiO2 ratio were significantly higher on the first 
and second postoperative day in the control group. Distribution of postoperative 
complications is shown in Table 6. 
 
 
 ScvO2 
(n=38) 
Control 
(n=41) 
p 
Infection 
Respiratory tract 0 1 0.33 
Abdominal 2 2 0.94 
Urinary tract 0 1 0.33 
Wound 0 0 - 
>24 hours of postoperative ventilation 1 5 0.11 
Cardiovascular 
Cardiac decompensation 0 0 - 
Arrhythmia 1 4 0.19 
Vasopressor need 9 14 0.31 
Acute myocardial infarction 0 0 - 
Stroke 0 0 - 
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Abdominal 
Constipation 2 3 0.71 
Upper GIT bleeding 0 1 0.33 
Reoperation 1 2 0.60 
Urine <500 ml/24 h or renal replacement  1 3 0.34 
Postoperative surgical bleeding 1 1 0.96 
Perioperative death 0 1 0.33 
Number of patients with any complication 10 19 0.07 
PaO2/FiO2 
     > 300 mmHg 4 3 0.62 
200-300 mmHg 24 15 0.02* 
100-200 mmHg 10 22 0.01* 
    < 100 mmHg 0 1 0.52 
Acute kidney 
injury 
no injury 27 29 0.59 
KDIGO 1 7 10 0.36 
KDIGO 2 3 1 0.28 
KDIGO 3 1 1 0.73 
Table 6.: postoperative complications 
 
There were no significant differences in any of the investigated inflammatory markers 
(CRP, leukocyte count, fever, microalbuminuria – data not shown) throughout the 
perioperative period. PCT also showed almost identical kinetics and absolute values in the 
two groups at t0-24-48 (ScvO2: 0.06 [0.00] - 0.66 [1.21] - 0.45 [0.98]; controls: 0.06 [0.01] - 
0.53 [1.4] - 0.42 [1.03] ng/ml, respectively). 
Discussion 
In this prospective randomised study we found that ScvO2 and MAP based intraoperative 
hemodynamic management resulted in more intraoperative interventions, better 
intraoperative diuresis and less pulmonary dysfunction in the postoperative period 
compared to a MAP and CVP guided therapy, however the overall complication rate was 
not reduced significantly. Although controversy still exists about the interpretation of 
ScvO2, it is universally accepted that “low” values suggest a global oxygen debt, imbalance 
between the oxygen supply and demand. The “target” or in other words “normal” 
intraoperative ScvO2 value remains uncertain. Theoretically ScvO2 should be “higher” than 
the physiological value determined in awaken subjects or found in patients in ICU, due to 
the reduced oxygen demand/consumption during general anaesthesia. Compared to the 
routinely used target level of ScvO2 in critical care, which is 70%, a number of studies 
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found higher values in the intraoperative settings. Therefore, in the current study we 
decided to use an interventional threshold of ScvO2≤75% or a decrease of >3%, and 
observed more therapeutic interventions compared to the MAP and CVP guided control 
group: patients received more colloid fluid and blood transfusions. Any decrease in DO2 
might have been recognised earlier by ScvO2 than CVP and resulted in more frequent 
interventions. These interventions possibly resulted in better tissue perfusion and oxygen 
delivery, also shown by the significantly better intraoperative diuresis which might have led 
to better outcomes. The aim of our study was to investigate the role of ScvO2 as an easily 
obtainable parameter in the hemodynamic therapy of high risk surgery. Continuous 
measurement of ScvO2 requires extra instrumentations, but we believe that similarly to the 
critical care repeated measurement of ScvO2 during the operation provides useful 
information regarding the hemodynamics of the patient and the necessity of any 
intervention (fluid bolus, vasoactive drug, transfusion). 
 
Conclusions 
 
Volumetric and pressure guided intraoperative fluid management 
1. We were not able to identify any significant difference regarding the effects of ITBV or 
CVP guided intraoperative fluid management on the postoperative inflammatory response 
following major abdominal surgery.  
 
2. The inflammatory response in the whole sample was attenuated compared to previous 
results and data. We think that this is due to the determined and fulfilled hemodynamic 
goals in both groups, which led to reduced intraoperative hypovolemia and hypoperfusion 
resulting in the attenuated inflammatory response.  
 
3. Both the changes of CVP and ITBV showed correlation with the changes of SVI, 
although the relationship was weak. During the planning of our study the investigation of 
this relationship was not one of our aims. Therefore, we cannot conclude that these two 
parameters are equivalent regarding the estimation of the cardiac preload.  
 
 
17 
 
Continuous central venous oxygen saturation assisted hemodynamic therapy during 
major abdominal surgery  
1. In accordance with previous results we found higher values of ScvO2 in the 
intraoperative setting compared to the levels used as target in critical care.  
 
2. ScvO2 guided intraoperative hemodynamic management resulted in more intraoperative 
fluid administration and transfusion and higher urinary output compared to CVP guided 
strategy.  
 
3. In the ScvO2 group the observed decrease of the central venous saturation from a 
supranormal value to the previously aimed target level could be explained with the 
improved microcirculation caused by higher fluid intake. This decrease was not detected in 
the CVP group.   
 
4. The occurrences of postoperative complications were lower in the ScvO2 group. The only 
significant difference was in the postoperative oxygenation, which was better in the group 
receiving more fluids. The explanation could be the improved hemodynamics and 
attenuated inflammatory response.  
 
5. Based on these results ScvO2 assisted intraoperative hemodynamic management may be 
a useful and at least equivalent alternative to CVP and may also lead to improved 
outcomes.  
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